96.
Lei P, Tian S, Teng C, Huang L, Liu X, Wang J, Zhang Y, Li B, Shan Y. “Sulforaphane
Improves Lipid Metabolism by Enhancing Mitochondrial Function and Biogenesis in Vivo
and In Vitro.” Molecular Nutrition & Food Research. Vol. 63, no. 4. (February 2019):
e1800795. doi: 10.1002 /mnfr.201800795.
97.
Huang DD, et al “Nrf2 Deficiency Exacerbates Frailty and Sarcopenia by Impairing Skeletal
Muscle Mitochondrial Biogenesis and Dynamics in an Age-Dependent Manner.”
Experimental
Gerontology.
Vol.
119.
(January
25,
2019):
617–3.
doi:
10.1016/j.exger.2019.01.022.
98.
Piechota-Polanczyk A, Kopacz A, Kloska D, Zgrapan B, Neumayer C, GrochotPrzeczek A,
Huk I, Brostjan C, Dulak J, Jozkowicz A.“Simvastatin Treatment Upregulates HO-1 in
Patients with Abdominal Aortic Aneurysm but Independently of Nrf2.” Oxidative Medicine
and Cellular Longevity. Vol. 2018, no. 28. (March 2018.) doi: 10.1155/2018/2028936.
99.
Smith RE, Tran K, Smith CC, McDonald M, Shejwalkar P, Hara K“The Role of the Nrf2/ARE
Antioxidant System in Preventing Cardiovascular Diseases.” Oxidative Medicine and
Cellular Longevity. Vol. 4, no. 4. (December 2016): 34.
100.
Jang HJ, Hong EM, Kim M, Kim JH, Jang J, Park SW, Byun HW, Koh DH, Choi MH, Kae
SH, Lee J. “Simvastatin Induces Heme Oxygenase-1 via NF-E2-Related Factor 2 (Nrf2)
Activation through ERK and PI3K/Akt Pathway in Colon Cancer.” Oncotarget. Vol. 7, no.
29. (July 19, 2016): 46219-46229. doi: 10.18632/oncotarget.10078.
101.
Leonardo CC, Doré S. “Dietary Flavonoids Are Neuroprotective through Nrf2-Coordinated
Induction of Endogenous Cytoprotective Proteins.” Nutritional Neuroscience. Vol. 14, no. 5.
(September 2011): 226–236. doi: 10.1179/1476830511Y.0000000013.
102.
Kumar H, Kim IS, More SV, Kim BW, Choi DK. “Natural Product-Derived Pharmacological
Modulators of Nrf2/ARE Pathway for Chronic Disease.” Natural Products Reports. Vol. 31,
no. 1. (January 2014): 109–139.
103.
Baird L, Dinkova-Kostova AT. “The Cytoprotective Role of the Keap1-Nrf2 Pathway.”
Archives oƒ Toxicology. Vol. 85, no. 4. (April 2011): 241–272.
104.
Gao B, Doan A, Hybertson BM. “The Clinical Potential of Nrf2 Signaling in Degenerative
and Immunological Disorders.” Journal oƒ Clinical Pharmacology. Vol. 6. (2014): 19–34.
105.
Sandberg M, Patil J, D’Angelo B, Weber SG, Mallard C. “NRF2-Regulation in Brain Health
and Disease: Implication of Cerebral Inflammation.” Neuropharmacology. Vol. 79. (2014):
298–306. doi: 10.1016/j .neuropharm.2013.11.004.
106.
Seo HA, Lee IK. “The Role of Nrf2: Adipocyte Differentiation, Obesity, and Insulin
Resistance.” Oxidative Medicine and Cellular Longevity. Vol. 2013. (2013): 184598.
107.
Pedruzzi LM, Stockler-Pinto MB, Leite M Jr., Mafra D. “Nrf2-keap1 System Versus NF-κB:
The Good and the Evil in Chronic Kidney Disease?” Biochimie. Vol. 94, no. 12. (December
2012): 2461–2466. doi: 10.1016/j.biochi.2012.07.015.
108.
Smolarek AK, So JY, Thomas PE, Lee HJ, Paul S, Dombrowski A, Wang CX, Saw CL, Khor
TO, Kong AN, Reuhl K, Lee MJ, Yang CS, SUh N. “Dietary Tocopherols Inhibit Cell
Proliferation, Regulate Expression of ERα, PPARγ, and Nrf2, and Decrease Serum
Inflammatory Markers During the Development of Mammary Hyperplasia.” Molecular
Carcinogenesis. Vol. 52. (2013): 514–525. doi: 10.1002 /mc.21886.
